UNITY Biotechnology tanks after failing to meet goal in eye disorder treatment trial
Source: SeekingAlpha
2025-03-24 09:29:48 ET
More on Unity Biotechnology
- Seeking Alpha’s Quant Rating on Unity Biotechnology
- Historical earnings data for Unity Biotechnology
- Financial information for Unity Biotechnology
Read the full article on Seeking Alpha
For further details see:
UNITY Biotechnology tanks after failing to meet goal in eye disorder treatment trial
Unity Biotechnology Inc.
NASDAQ: UBX
UBX Trading
-41.13% G/L:
$0.2001 Last:
3,847,602 Volume:
$0.2824 Open:
UBX Latest News
UBX Stock Data
$965,603
15,835,198
1.75%
7
551621%
Biotechnology & Life Sciences
Healthcare
US
South San Francisco
